LakeShore Biopharma Co., Ltd.
LSBCFOTCHealthcare · Pharmaceutical Preparations · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 20-Fmissed a reporting deadline ↗Jul 31, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4,076 | 1.9 | 0.0% |
| Apr 30, 2026 | 4,076 | 1.6 | -0.1% |
| Apr 15, 2026 | 4,079 | 1.0 | -0.6% |
| Mar 31, 2026 | 4,103 | 1.9 | -0.1% |
| Mar 13, 2026 | 4,106 | 1.0 | -0.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 28, 2026
- SC 13E3/AAMENDMENT NO. 7 TO SCHEDULE 13E-3May 28, 2026
- SC 13E3/AAMENDMENT NO. 6 TO SCHEDULE 13E-3May 8, 2026
- SCHEDULE 13D/AApr 29, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 29, 2026
- 3Apr 10, 2026
- 3Apr 10, 2026
- 3OWNERSHIP DOCUMENTApr 1, 2026
- 3OWNERSHIP DOCUMENTApr 1, 2026
- 3OWNERSHIP DOCUMENTApr 1, 2026
- 3OWNERSHIP DOCUMENTApr 1, 2026
- SC 13E3/AAMENDMENT NO. 5 TO SCHEDULE 13E-3Apr 1, 2026
- 3Mar 31, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 25, 2026
- SCHEDULE 13D/AMar 25, 2026